Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome.

Nutrients. 2022;14(2)
Full text from:

Plain language summary

Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction, formerly known as a functional gastrointestinal (GI) disorder. Apart from abdominal pain, altered stool frequency, diarrhoea, and constipation, a large proportion of patients with IBS also experience other GI symptoms such as abdominal distention, bloating and flatulence. The aim of this study was to investigate predictors of treatment response to the low FODMAP (short-chain carbohydrates, i.e., fermentable oligo-, di-, monosaccharides, and polyols) and the traditional IBS diet while focusing on the four core IBS symptoms (bloating, constipation, diarrhoea, and pain). This study was a post-hoc analysis of a previously published randomised controlled trial. In total, 33 patients on low FODMAP diet and 34 patients on the traditional IBS diet were included in the analysis. Results showed that patterns of psychological, dietary, and microbial factors can predict IBS symptom response to two dietary advice systems—the traditional IBS and the low FODMAP diet. A clinical profile with less severe IBS features appears to predict a better symptom-specific response to both dietary interventions. Authors conclude that larger prospective randomised controlled trials which include different treatment approaches are required as they may help to optimize personalized treatment algorithms in IBS.

Expert Review


Conflicts of interest: None

Take Home Message:
  • Dietary intervention for IBS related symptoms was efficacious for up to 75% of patients in this study
  • Recommendation for a traditional IBS dietary intervention should supersede the low-FODMAP diet, with the latter only implemented when symptoms persist.

Evidence Category:
  • X A: Meta-analyses, position-stands, randomized-controlled trials (RCTs)
  • B: Systematic reviews including RCTs of limited number
  • C: Non-randomized trials, observational studies, narrative reviews
  • D: Case-reports, evidence-based clinical findings
  • E: Opinion piece, other

Summary Review:
Introduction

This randomised controlled intervention study of 67 individuals fulfilling the Rome III criteria for IBS drew comparisons between the efficacy of the traditional IBS diet - as directed by the British Dietetic Association and National Institute for Health and Care Excellence (NICE) - and the low fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs) diet on specific IBS-related symptoms (pain, constipation, diarrhoea, and bloating).

Methods

A 10-day screening period included faecal sample analysis, 4-day food diary (pre-randomisation and last week of intervention), and daily stool diary (Bristol Stool Form scale). After 10 days, patients compiled several GI and non-GI related questionnaires, inclusive of IBS severity scoring system (IBS-SSS). Patients who scored ≥175 for the IBS-SSS were randomly allocated to follow either a low-FODMAP or traditional IBS diet for a period of 4-weeks. Thorough explanations were provided by trained Dietitians. During intervention, patients compiled symptom questionnaires (Gastrointestinal Symptoms Rating Scale-IBS) on a weekly basis.

Results

  • Both diets reduced symptoms of pain, diarrhoea and bloating (all p<0.0001), but not constipation (p=0.15)
  • There was no difference between following the traditional IBS diet and low-FODMAP diet in terms of pain (p=0.80), constipation (p=0.63), diarrhoea (p=0.96) and bloating (p=0.35)
  • Less severe gut dysbiosis was weakly associated with better dietary response and improvement of constipation (p=0.05)
  • Higher energy intake at baseline predicted better pain improvement with both dietary types compared to lower energy intake (p=0.03)
  • More severe psychological distress predicted worse intervention response for bloating (p=0.03)
  • Higher baseline oligosaccharide intake predicted a worse response to the low FODMAP diet (p=0.01) but not the traditional IBS diet (p=0.16).

Conclusion

This study demonstrated that based on 4 distinct IBS-related symptomatology, better treatment response to 2 different dietary strategies was noted in patients with less severe clinical characteristics. Higher energy intake at baseline and gut dysbiosis scores that were similar to healthy controls were associated with better improvements following dietary interventions. Thus patients who already follow a calorie restricted diet and who have more significant gut dysbiosis profiles might need more bespoke intervention. Severe psychological distress patients responded worse to both diets.

Clinical practice applications:
  • Even a short 4-week specific dietary intervention (low FODMAP or traditional IBS diet) can result in IBS-related symptomatic improvement for pain, bloating, and diarrhoea, but not constipation
  • The preferred starting point for dietary intervention should be the traditional IBS diet given its relative ease to follow
  • The more restrictive low FODMAP protocol could be considered if symptoms persist
  • More bespoke interventions are required for patients who suffer with severe psychological stress, have tested and found gut dysbiosis, and individuals who already follow a restrictive diet.

Considerations for future research:
  • Future studies need to include not only larger but more diverse cultural and socio-economic cohorts to ascertain the efficacy of IBS symptom-related dietary interventions
  • Longer periods of intervention are needed to confirm dietary intervention efficacy.

Abstract

(1) Background: Predictors of dietary treatment response in irritable bowel syndrome (IBS) remain understudied. We aimed to investigate predictors of symptom improvement during the low FODMAP and the traditional IBS diet for four weeks. (2) Methods: Baseline measures included faecal Dysbiosis Index, food diaries with daily energy and FODMAP intake, non-gastrointestinal (GI) somatic symptoms, GI-specific anxiety, and psychological distress. Outcomes were bloating, constipation, diarrhea, and pain symptom scores treated as continuous variables in linear mixed models. (3) Results: We included 33 and 34 patients on the low FODMAP and traditional IBS diet, respectively. Less severe dysbiosis and higher energy intake predicted better pain response to both diets. Less severe dysbiosis also predicted better constipation response to both diets. More severe psychological distress predicted worse bloating response to both diets. For the different outcomes, several differential predictors were identified, indicating that baseline factors could predict better improvement in one treatment arm, but worse improvement in the other treatment arm. (4) Conclusions: Psychological, nutritional, and microbial factors predict symptom improvement when following the low FODMAP and traditional IBS diet. Findings may help individualize dietary treatment in IBS.

Lifestyle medicine

Fundamental Clinical Imbalances : Digestive, absorptive and microbiological
Patient Centred Factors : Mediators/Irritable bowel syndrome
Environmental Inputs : Microorganisms
Personal Lifestyle Factors : Nutrition
Functional Laboratory Testing : Stool

Methodological quality

Jadad score : Not applicable
Allocation concealment : Not applicable

Metadata